Detected ·
Cellares
——
Cellares raised $277M in Series D, with ARK Investment Management joining with a $20M investment. The cell therapy manufacturing company has delivered its first GMP doses and signed commercial agreements with Cabaletta Bio and TScan Therapeutics.
- Website
- www.cellares.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-12 20:05:21 UTC
- Signal ID
- a605c1fd-9912-4b02-8030-8c57eac7cf01
As the API returns it
{
"id": "a605c1fd-9912-4b02-8030-8c57eac7cf01",
"created_at": "2026-06-12T20:05:21.042083Z",
"company_name": "Cellares",
"company_website_url": "www.cellares.com",
"company_linkedin_url": "https://www.linkedin.com/company/cellares-corporation",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Cellares raised $277M in Series D, with ARK Investment Management joining with a $20M investment. The cell therapy manufacturing company has delivered its first GMP doses and signed commercial agreements with Cabaletta Bio and TScan Therapeutics.*"
}